13 months, respectively), median overall survival was 15 months with a nonsignificant trend in favor of patients without PVT (18 months) versus with PVT (13 months), objective response was 40.4%, and mortality at 30––90 days was 0–3.8%.
← all excerpts
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
1
—
—